DONGKOO BIO & PHARMA CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 006620 for the last quarter is 61.31 B KRW, and it's 4.52% lower compared to the previous quarter. The net income of Q2 24 is 2.28 B KRW.